Search results for "Geriatrics"

showing 10 items of 1388 documents

Safety Considerations of Inhaled Corticosteroids in the Elderly

2014

Inhaled corticosteroids (ICSs) are widely used in the treatment of patients with chronic obstructive pulmonary diseases. However, high-dose regimens and long-term use of ICSs have the potential to cause a variety of local and systemic side effects such as candidiasis, cataracts, glaucoma, and osteoporosis. The use of ICSs can also be associated with the risk of bone fractures, diabetes mellitus and pneumonia. These ICS-related side effects are of particular importance in elderly patients due to the presence of comorbidities and age-related behavioral, cognitive, and psychological problems, which can all interact with inhaled treatment. We reviewed the available literature on the clinically …

Budesonidemedicine.medical_specialtyOsteoporosisSettore MED/10 - Malattie Dell'Apparato RespiratorioFluticasone propionatePulmonary Disease Chronic ObstructivePharmacotherapyCataractsAdrenal Cortex HormonesDiabetes mellitusAdministration InhalationmedicineHumansPharmacology (medical)asthma corticosteroidsIntensive care medicineAgedCOPDbusiness.industrymedicine.diseaseAsthmaPneumoniaTreatment OutcomePhysical therapyGeriatrics and Gerontologybusinessmedicine.drugDrugs & Aging
researchProduct

Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 Mice

2021

Background: In Alzheimer’s disease (AD), an increase in inflammation is distinctive. Amyloid precursor protein plus presenilin-1 (APP/PS1 mice) is a model for this illness. Chemokines secreted by central nervous system (CNS) cells could play multiple important roles in AD. Data looking for the chemokines involved in inflammatory mechanisms are lacking. To understand the changes that occur in the inflammation process in AD, it is necessary to improve strategies to act on specific inflammatory targets. Objective: Chemokines and their receptors involved in phagocytosis, demyelination, chemotaxis, and coagulation were the objective of our study. Methods: Female APPswe/PS1 double-transgenic mice…

CCR1CCR2ChemokineCCR3CCR4Mice TransgenicCCL7Amyloid beta-Protein PrecursorMiceChemokine receptorAlzheimer Diseasemental disordersAnimalsInflammationAmyloid beta-PeptidesbiologyGeneral NeuroscienceBrainChemotaxisGeneral MedicineDisease Models AnimalPsychiatry and Mental healthClinical PsychologyImmunologybiology.proteinFemaleReceptors ChemokineChemokinesGeriatrics and GerontologyJournal of Alzheimer's Disease
researchProduct

Angioimmunoblastic T-cell lymphoma

2008

Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive neoplasm clinically characterized by sudden onset of constitutional symptoms, lymphadenopathy, hepatosplenomegaly, frequent autoimmune phenomena, particularly hemolytic anemia and thrombocytopenia, and polyclonal hypergammaglobulinemia. The lymph node histological picture is also distinctive, constituted by a polymorphic infiltrate, a marked proliferation of high endothelial venules, and a dense meshwork of dentritic cells. The neoplastic CD4+ T-cells represent a minority of the lymph node cell population; its detection is facilitated by the aberrant expression of CD10. Almost all cases arbor an EBV infected B-cell populatio…

CD4-Positive T-LymphocytesMaleEpstein-Barr Virus InfectionsPathologyAutologous transplantHerpesvirus 4 HumanHepatosplenomegalyImmunosuppressive AgentEpstein-Barr Virus InfectionHypergammaglobulinemiaLymph nodeNon-Hodgkin lymphomaAngioimmunoblastic lymphomaB-Lymphocyteseducation.field_of_studyB-LymphocyteLymph NodeHematologyThalidomideSurvival RateTransplantation Autologoumedicine.anatomical_structureOncologyCD4-Positive T-LymphocyteFemaleNeprilysinmedicine.symptomImmunosuppressive AgentsHumanmedicine.medical_specialtyAngioimmunoblastic T-cell lymphomaPopulationHigh endothelial venulesDendritic CellLymphoma T-CellTransplantation AutologousmedicineHumanseducationCell Proliferationbusiness.industryPeripheral T-cell lymphomaDendritic Cellsmedicine.diseasePeripheral T-cell lymphomaLymphomaTransplantationImmunologyLymph NodesGeriatrics and GerontologybusinessStem Cell Transplantation
researchProduct

Building an advocacy model to improve the dementia-capability of health plans in California

2021

Background Given the high and growing prevalence of Alzheimer's disease and related dementias, and the intensity of this population's care needs, it is imperative that healthcare systems increase their capacity to effectively serve people living with dementia (PLwD). The Dementia Cal MediConnect (Dementia CMC) project proposes an advocacy model that may foster dementia-capable systems change. Methods The Dementia CMC project was a 5-year partnership (2013-2018) between local Alzheimer's organizations and 10 managed care health plans (HPs) in California's duals demonstration. It used an advocacy model with the following steps: (1) Identify dementia-capable best practices to set as systems ch…

Capacity BuildingSystems AnalysisReferralBest practicePopulationPatient AdvocacyPublic-Private Sector PartnershipsCaliforniaNursingAlzheimer DiseaseHumansMedicineDementiaBusiness caseeducationeducation.field_of_studyGovernmentbusiness.industrymedicine.diseaseOrganizational InnovationGeneral partnershipVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Geriatri: 778Managed careDementiasense organsGeriatrics and GerontologybusinessDelivery of Health Care
researchProduct

Role of a medication in polyurethane foam in the treatment of diabetic foot lesions

2010

Background The treatment of diabetic foot lesions need medications capable of managing wound infection and exudates that, variously combined, can influence the natural history of the pathology and therefore limb survival. A particular and economic device, is represented by honeycomb structure polyurethane foam Ligasano ©.

Cardiovascular eventmedicine.medical_specialtyPathologybusiness.industryGeriatrics gerontologyTissue samplemedicine.diseaseDiabetic footWound infectionInfected woundSurgerySettore MED/18 - Chirurgia Generalepolyurethane foam diabetic foot lesionsmedicineGeriatrics and GerontologyMeeting abstractbusinessBMC Geriatrics
researchProduct

Can Alzheimer disease be a form of type 3 diabetes?

2012

Alzheimer disease (AD) and metabolic syndrome are two highly prevalent pathological conditions of Western society due to incorrect diet, lifestyle, and vascular risk factors. Recent data have suggested metabolic syndrome as an independent risk factor for AD and pre-AD syndrome. Furthermore, biological plausibility for this relationship has been framed within the “metabolic cognitive syndrome” concept. Due to the increasing aging of populations, prevalence of AD in Western industrialized countries will rise in the near future. Thus, new knowledge in the area of molecular biology and epigenetics will probably help to make an early molecular diagnosis of dementia. An association between metabo…

Central Nervous SystemAgingmedicine.medical_specialtySingle-nucleotide polymorphismType 2 diabetesBiologyBioinformaticsPolymorphism Single NucleotideSHIP2 ADAlzheimer DiseaseRisk FactorsDiabetes mellitusInternal medicinemedicineDiabetes MellitusDementiaHumansInsulinEpigeneticsRisk factorLife StyleAgedSettore MED/04 - Patologia GeneraleMetabolic SyndromeInositol Polyphosphate 5-PhosphatasesSyndromeModels Theoreticalmedicine.diseasePhosphoric Monoester HydrolasesEndocrinologySettore MED/26 - NeurologiaGeriatrics and GerontologyAlzheimer's diseaseMetabolic syndromeCognition DisordersSignal TransductionRejuvenation research
researchProduct

What are the effects of the aging of the neuromuscular system on postural stability?

2015

International audience; Aging is frequently associated with a decreased postural stability, essentially after 60 years, leading to an increased risk of falling. In this article we propose to highlight the influence of the aging of the neuromuscular system on postural stability when standing upright. To maintain balance while standing upright, human needs to control the activity of ankle muscles and particularly the plantar flexors. During the aging process, the performance of these muscles are strongly altered. It is commonly observed large deficits in elderly people with history of falls. Some authors reported an inverse correlation between the amplitude of postural sway and the capacity o…

Central Nervous SystemMale030506 rehabilitationnursing-home residents0302 clinical medicineelderly adultsElderly peopleolder-adultsrisk-factorsPostural BalanceAged 80 and overNeuropsychology and Physiological Psychologymedicine.anatomical_structurePostural stabilitytriceps suraeFemale[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]0305 other medical scienceFalling (sensation)medicine.medical_specialtysoleus h-reflexfallmechanical-propertieshuman skeletal-musclePhysical exercise03 medical and health sciencesPhysical medicine and rehabilitationankle muscleslength-tension relationshipmedicineHumansInverse correlationMuscle SkeletalBiological PsychiatryBalance (ability)Agedbusiness.industryagingage-related-changesbalance controlIncreased riskpostural stability[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Physical therapyAccidental FallsNeurology (clinical)Geriatrics and GerontologyAnklebusiness030217 neurology & neurosurgery
researchProduct

2019

Abstract Background In old age, decline in functioning may cause changes in walking ability. Our aim was to study whether older people who report adaptive, maladaptive, or no walking modifications differ in outdoor mobility. Methods Community-dwelling people aged 75–90 years (N = 848) were interviewed at baseline, of whom 761 participated in the 2-year follow-up. Walking modifications were assessed by asking the participants whether they had modified their way of walking 2 km due to their health. Based on the responses, three categories were formed: no walking modifications (reference), adaptive (eg, walking more slowly, using an aid), and maladaptive walking modifications (reduced frequenc…

Change over timeAging030505 public healthbusiness.industryPhysical activityOdds ratioPhysical functionConfidence interval03 medical and health sciences0302 clinical medicineMedicine030212 general & internal medicineGeriatrics and Gerontology0305 other medical scienceOlder peoplebusinessDemographyThe Journals of Gerontology Series A: Biological Sciences and Medical Sciences
researchProduct

Is loneliness associated with mild cognitive impairment in low- and middle-income countries?

2021

Background: Loneliness may be a risk factor for mild cognitive impairment but studies on this topic are scarce, particularly from low- and middle-income countries (LMICs). Therefore, the aim of the present study was to investigate the association between loneliness and mild cognitive impairment (MCI) in six LMICs (China, Ghana, India, Mexico, Russia and South Africa). Methods: Cross-sectional, community-based, nationally representative data from the WHO Study on global AGEing and adult health (SAGE) were analyzed. The definition of MCI was based on the National Institute on Ageing-Alzheimer's Association criteria. Multivariable logistic regression analysis and meta-analysis were conducted t…

ChinaLogistic regression*multi-countryOdds*loneliness03 medical and health sciences0302 clinical medicinemild cognitive impairmentMESH: Aged; China/epidemiology; Cognitive Dysfunction/epidemiology; Cross-Sectional Studies; Developing Countries; Humans; Loneliness; Middle Aged; PrevalencemedicinePrevalencelonelinessDementiaHumansCognitive Dysfunctionlow- and middle-income countriesRisk factorCognitive impairmentDeveloping CountriesAgedmulti-country030214 geriatricsbusiness.industryLonelinessMiddle Agedmedicine.disease*low- and middle-income countriesConfidence interval3. Good healthPsychiatry and Mental healthCross-Sectional Studies*mild cognitive impairmentLow and middle income countriesloneliness low- and middle-income countries mild cognitive impairment multi-country[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieGeriatrics and Gerontologymedicine.symptombusinessDemography
researchProduct

STATINS FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS IN ELDERLY PATIENTS: A PICTURE FROM CLINICAL PRACTICE WITHOUT STRONG EVIDENCE FROM CLINIC…

2008

Clinical trialClinical Practicemedicine.medical_specialtybusiness.industryPrimary preventionIncidence (epidemiology)medicineAlternative medicinePhysical therapyMEDLINEGeriatrics and GerontologyIntensive care medicinebusinessJournal of the American Geriatrics Society
researchProduct